Lyden PD - Search Results

1

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.

Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, Grotta JC, Ashwood TJ, Hardemark HG, Svensson HH, Rodichok L, Wasiewski WW, Ahlberg G; CHANT Trial Investigators. Lyden PD, et al. Stroke. 2007 Aug;38(8):2262-9. doi: 10.1161/STROKEAHA.106.472746. Epub 2007 Jun 14. Stroke. 2007. PMID: 17569876 Clinical Trial.

2

Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.

Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J. Lyden P, et al. Stroke. 1994 Nov;25(11):2220-6. doi: 10.1161/01.str.25.11.2220. Stroke. 1994. PMID: 7974549 Clinical Trial.

3

Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial.

Tilley BC, Marler J, Geller NL, Lu M, Legler J, Brott T, Lyden P, Grotta J. Tilley BC, et al. Stroke. 1996 Nov;27(11):2136-42. doi: 10.1161/01.str.27.11.2136. Stroke. 1996. PMID: 8898828 Clinical Trial.

4

Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators.

Lyden P, Lu M, Jackson C, Marler J, Kothari R, Brott T, Zivin J. Lyden P, et al. Stroke. 1999 Nov;30(11):2347-54. doi: 10.1161/01.str.30.11.2347. Stroke. 1999. PMID: 10548669

5

Effect of ganaxolone in a rodent model of cerebral hematoma.

Lyden P, Shin C, Jackson-Friedman C, Hassid S, Chong A, Macdonald RL. Lyden P, et al. Stroke. 2000 Jan;31(1):169-75. doi: 10.1161/01.str.31.1.169. Stroke. 2000. PMID: 10625734

6

Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity.

Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Meyer BC, et al. Among authors: lyden pd. Stroke. 2002 May;33(5):1261-6. doi: 10.1161/01.str.0000015625.87603.a7. Stroke. 2002. PMID: 11988601 Clinical Trial.

7

A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke.

Haley EC Jr, Lyden PD, Johnston KC, Hemmen TM; TNK in Stroke Investigators. Haley EC Jr, et al. Among authors: lyden pd. Stroke. 2005 Mar;36(3):607-12. doi: 10.1161/01.STR.0000154872.73240.e9. Epub 2005 Feb 3. Stroke. 2005. PMID: 15692126

8

Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.

Lu M, Lyden PD, Brott TG, Hamilton S, Broderick JP, Grotta JC. Lu M, et al. Among authors: lyden pd. J Neurosci Methods. 2005 Apr 30;143(2):209-16. doi: 10.1016/j.jneumeth.2004.10.002. Epub 2004 Dec 8. J Neurosci Methods. 2005. PMID: 15814153

9

Alteplase for acute stroke revisited: the first 10 years.

Lyden PD, Lees KR, Davis SM. Lyden PD, et al. Lancet Neurol. 2006 Sep;5(9):722-4. doi: 10.1016/S1474-4422(06)70530-0. Lancet Neurol. 2006. PMID: 16914399 No abstract available.

10

An expedited code stroke protocol is feasible and safe.

Sattin JA, Olson SE, Liu L, Raman R, Lyden PD. Sattin JA, et al. Among authors: lyden pd. Stroke. 2006 Dec;37(12):2935-9. doi: 10.1161/01.STR.0000249057.44420.4b. Epub 2006 Nov 9. Stroke. 2006. PMID: 17095736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page